We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

10 hedge funds and large institutions have $10.2M invested in Soleno Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

853% more capital invested

Capital invested by funds: $1.07M → $10.2M (+$9.1M)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

51.67% more ownership

Funds ownership: 3.74% → 55.41% (+52%)

25% more funds holding

Funds holding: 8 → 10 (+2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$693K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$34.9K
3
BFA
BlackRock Fund Advisors
California
+$1.08K
4
Citigroup
Citigroup
New York
+$98

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$54K
2
UBS Group
UBS Group
Switzerland
-$22.3K
3
Morgan Stanley
Morgan Stanley
New York
-$12.3K
4
TRCT
Tower Research Capital (TRC)
New York
-$10.8K

SLNO Hedge Fund Activity: Q1 2016 in Review

10 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q1 2016, worth a combined $10.2M — up 853% from $1.07M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SLNO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $693K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $54K sold.

  • 10 institutional investors held Soleno Therapeutics (SLNO) as of Q1 2016, up from 8 in Q4 2015.
  • Funds reported $10.2M of Soleno Therapeutics stock for Q1 2016, up 853% quarter-over-quarter.
  • 4 funds opened new Soleno Therapeutics positions in Q1 2016 and 2 closed out, a net change of +2 holders.
  • The largest Soleno Therapeutics buyer in Q1 2016 was Sabby Management, an estimated $693K added.
  • The largest Soleno Therapeutics seller in Q1 2016 was Virtu KCG Holdings, an estimated $54K sold.

Based on aggregated 13F filings for Q1 2016.